Next Article in Journal
Adding Some “Splice” to Stress Eating: Autophagy, ESCRT and Alternative Splicing Orchestrate the Cellular Stress Response
Next Article in Special Issue
Epigenetic Alterations in Prescription Opioid Misuse: New Strategies for Precision Pain Management
Previous Article in Journal
Genetic Variation in the ASTN2 Locus in Cardiovascular, Metabolic and Psychiatric Traits: Evidence for Pleiotropy Rather Than Shared Biology
Previous Article in Special Issue
The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 12
Issue 8
10.3390/genes12081195
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Rhythmic Regulation of DNA Methylation Factors and Core-Clock Genes in Brain Structures Activated by Cocaine or Sucrose: Potential Role of Chromatin Remodeling

by
Lamis Saad
1,2,3,
Andries Kalsbeek
2,3,*,
Jean Zwiller
1,4 and
Patrick Anglard
1,5,*
1
Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), UMR 7364 CNRS, Université de Strasbourg, Neuropôle de Strasbourg, 67000 Strasbourg, France
2
The Netherlands Institute for Neuroscience (NIN), Royal Netherlands Academy of Arts and Sciences (KNAW), 1105 BA Amsterdam, The Netherlands
3
Department of Endocrinology and Metabolism, Amsterdam UMC, University of Amsterdam, 1066 EA Amsterdam, The Netherlands
4
CNRS, Centre National de la Recherche Scientifique, 75016 Paris, France
5
INSERM, Institut National de la Santé et de la Recherche Médicale, 75013 Paris, France
*
Authors to whom correspondence should be addressed.
Genes 2021, 12(8), 1195; https://doi.org/10.3390/genes12081195
Submission received: 5 July 2021 / Revised: 28 July 2021 / Accepted: 29 July 2021 / Published: 31 July 2021
(This article belongs to the Special Issue Gene Expression and Chromatin Modification in the Brain)
Browse Figures
Versions Notes

Abstract

:
The circadian system interacts with the mesocorticolimbic reward system to modulate reward and memory in a time-of-day dependent manner. The circadian discrimination of reward, however, remains difficult to address between natural reinforcers and drugs of abuse. Circadian rhythms control cocaine sensitization and conversely cocaine causes long-term alteration in circadian periodicity in part through the serotonergic neurotransmission. Since neural circuits activated by cocaine and natural reinforcers do not completely overlap, we compared the effect of cocaine with that of sucrose, a strong reinforcer in rodents, by using passive chronic administration. The expression of fifteen genes playing a major role in DNA methylation (Dnmts, Tets), circadian rhythms (Clock, Bmal1, Per1/2, Cry1/2, Rev-Erbβ, Dbp1), appetite, and satiety (Orexin, Npy) was analyzed in dopamine projection areas like the prefrontal cortex, the caudate putamen, and the hypothalamus interconnected with the reward system. The corresponding proteins of two genes (Orexin, Per2) were examined by IHC. For many factors controlling biological and cognitive functions, striking opposite responses were found between the two reinforcers, notably for genes controlling DNA methylation/demethylation processes and in global DNA methylation involved in chromatin remodeling. The data are consistent with a repression of critical core-clock genes by cocaine, suggesting that, consequently, both agents differentially modulate day/night cycles. Whether observed cocaine and sucrose-induced changes in DNA methylation in a time dependent manner are long lasting or contribute to the establishment of addiction requires further neuroepigenetic investigation. Understanding the mechanisms dissociating drugs of abuse from natural reinforcers remains a prerequisite for the design of selective therapeutic tools for compulsive behaviors.

1. Introduction

Drugs of abuse and natural reinforcers such as food or sugar activate some common brain structures of the mesocorticolimbic reward system and can lead to addiction characterized by a compulsive behavior despite the awareness of negative effects. However, functional magnetic resonance imaging [1], as well as electrophysiological [2,3] and molecular studies [4,5] have shown that their activated neural circuits do not completely overlap. How they differ in triggering various behaviors remains an open issue. Drugs of abuse have been shown to exert their action, at least partially, by regulating epigenetic mechanisms controlling transcription. In an earlier study, we showed that cocaine was modulating the expression of epigenetic factors, highlighting serotonin-elevating agents as a major component in neurotransmission involved in this modulation and in chromatin remodeling [6,7], as in other drugs of abuse [8]. Among these factors, the regulation of methyl-CpG-binding proteins MeCP2 considered as a major epigenetic factor [9] and MBD1 suggested that post-mitotic neurons could reinterpret the DNA methylation code they acquired during early development. Moreover, cocaine was found to regulate DNA methyltransferases (Dnmts) and ten-eleven translocation (Tets) methylcytosine dioxygenases expression controlling DNA methylation and demethylation processes [5,10,11]. Consistent with these findings, DNA methylation of genes such as the cyclin-dependent kinase-like 5 [12] involved in the “early-onset seizure” variant of Rett syndrome [13], the memory suppressor gene protein phosphatase-1 [11,14], Homer2 regulating glutamate signaling and synaptic plasticity [15] and the Orexin receptor-1 gene [5] regulating the reinforcing and rewarding properties of cocaine [16] has been reported to be modulated by cocaine. In addition, genome-wide DNA methylation studies support a crucial role of DNA methylation in drug-induced behaviors [17,18,19,20]. It is now clear that DNA methylation is not restricted to behaviors including addiction, but also plays a prominent role in learning and memory processes [21], in neurodevelopmental-associated disorders [22], or in diet choice [23], and developmental timing [24]. The circadian system interacts with the mesocorticolimbic reward system to modulate reward and memory in a time-of-day dependent manner [25] although the circadian discrimination of reward still remains difficult to address between drugs of abuse and natural reinforcers, as previously reported [26]. Cocaine sensitization and reward are under the control of circadian genes and rhythms [27] and conversely, cocaine causes long-term alteration in circadian periodicity [28] in part through the serotonergic neurotransmission [29,30]. Dynamic DNA methylation changes in circadian clock genes also result from clock misregulation in cancer [31] and changes in circadian period length have been shown to require de novo DNA methylation [32]. On the other hand, methyl donors and Dnmt inhibitors regulate cocaine sensitization and self-administration [33,34,35,36] similar to orexin-receptor antagonists inhibiting cocaine-induced behavior in preclinical trials [37,38,39,40]. A few studies have also provided evidence for the regulation of orexin and of their receptors by DNA methylation in embryonic stem cells, in cancer, in depressive disorders and in response to drugs of abuse [5,41,42,43,44]. As recently reported, the orexin system function extends beyond general reward seeking and plays a critical role in expression of the multiphenotype addiction-like state [45].
In the present study, we compare the effects of repeated cocaine intake with that of sucrose on genes and proteins playing a major role in DNA methylation, circadian rhythms, appetite, and satiety. Our data highlight major differences in the mechanisms by which cocaine and sucrose, a strong natural reinforcer in rodents, differ in triggering molecular and cellular changes in rat dopaminergic brain projection areas and in the hypothalamus.

2. Materials and Methods

2.1. Animals

Male Wistar rats, 7–8 weeks old at their arrival in the laboratory and weighting 160–180 g, were housed in standard home cages in a temperature and humidity-controlled room with a 12 h/12 h light/dark cycle with lights on at 7.00 am (Zeitgeber time ZT0) and lights off at 7 p.m. (ZT12). ZT is a standardized 24-h notation of the phase in which ZT0 indicates the beginning of light phase and ZT12 the beginning of the dark phase. All rats were allowed to acclimate to laboratory conditions and were handled during one week before experimental procedures started and had ad libitum access to food and water. They were then treated by cocaine hydrochloride i.p. injections (20 mg/kg) or by sucrose (1 mL/15% solution) passive oral intake once a day for 10 days at ZT1. Cocaine control rats were injected with an equivalent volume of saline (0.9% NaCl), while sucrose control rats received an equivalent volume of water. Rats were anesthetized with 1 mL of Dolethal (100 mg/kg i.p.) prior to being killed 5 h, 10 h, or 15 h after the last treatment. All procedures involving animal care were conducted in compliance with national laws and policies (Council directive 87848, 1987, Service Vétérinaire de la Santé et de la Protection animale, permission 67–165 to J.Z., with the Ministère de l’Education Nationale de l’Enseignement Supérieur et de la Recherche (project permission number APAFIS#2133-20151 00,221 087,072 to P.A.) and with international guidelines (NIH publication 5586-23, 1985). They have also been carried out in accordance with international guidelines on animal experimentation of the Netherlands Institute for Neuroscience (NIN) and with approval by the Animal Care Committee of the Royal Netherlands Academy of Arts and Sciences (KNAW, Amsterdam, The Netherlands).

2.2. Brain Dissection and RNA Extraction

Brain structures of interest were dissected (Supplementary Figure S1) and frozen at −80 °C, as previously described) [11]. Total RNA was then extracted from the rat medial prefrontal cortex (PFCx) and the caudate putamen (CPu) and its concentration was evaluated using a Nanodrop spectrophotometer while RNA was stored at −20 °C, as previously described [5].

2.3. Reverse Transcription-Quantitative PCR Analysis

Briefly, 0.5 μg of total RNA was reverse transcribed using random primers and Reverse Transcriptase (MLV). The reaction product was used for real time PCR performed with Hot Pol EvaGreen according to the manufacturer’s instructions (Euromedex, Souffelweyersheim, France) with a CFX Connect Real Time PCR detection System (Bio-Rad), as previously described [12]. Primers listed in Table 1 were from Sigma-Aldrich (Saint Louis, MO, USA) and were designed with Primer 3 software. Results were normalized to 36B4 (RPLP0) and used as an internal control for gene expression. Cycling conditions were: 95 °C for 14 min, then 45 cycles of 95 °C for 14 s, 60 °C for 18 s, and 72 °C for 18 s. Properties of PCR products were analyzed by melting curve analysis and their expected sizes were confirmed by 2% agarose gel electrophoresis.

2.4. Global DNA Methylation Analysis

High molecular weight DNA was extracted from the PFCx and the CPu at ZT16, as previously described [46]. The 5mC levels were evaluated by using a widely used ELISA colorimetric kit (EPIGENTEKTM Global DNA Quantification Ultra Kit, NY, USA) [47]. Absorbance was determined on a microplate reader at 450 nm. The protocol and calculation of DNA methylation were carried on according to the manufacturer’s instructions.

2.5. Immunohistochemistry

Animals used for immunohistochemistry studies were perfused intracardially with saline (0.9% NaCl) followed by 4% paraformaldehyde in 0.1 m phosphate buffer, pH 7.4. Brains were rapidly removed and post-fixed in the same buffer overnight at 4 °C, then cryoprotected in 20% sucrose for 48 h at 4 °C prior to being frozen in isopentane at −40 °C and stored at −80 °C. Coronal sections of 30 μm thickness were prepared and stored at −20 °C in free floating cryoprotectant solution. Prior to staining, antigen retrieval was performed by incubating sections in citrate buffer at 90° C for 10 min. Immunohistochemical staining was carried out using Orexin-A goat polyclonal antibody (C-19, Santa Cruz, sc-8070, 1:3000) or Per2 rabbit polyclonal antibody (Millipore, ab2202, 1:2000) or FosB rabbit monoclonal antibody (Cell Signaling Technology, 5G4, cs-2251, 1:2000) also recognizing the ∆FosB truncated isoform. The specificity of primary antibodies was described by the suppliers and by other studies for Orexin-A [5,48], Per2 [49,50] and FosB [51,52]. Floating sections were washed in TBS, at pH 7.6, and incubated in a solution of 3% H2O2 (30% hydrogen peroxide, Sigma-Aldrich) in TBS for 10 min and rinsed with TBS for 10 min three times prior to their incubation with primary antibodies overnight at 4 °C. Biotinylated secondary antibodies were incubated for 2 h at room temperature (1:400) followed by avidin-biotin complex (ABC Vectastain Kit, Vector Laboratories) for 1 h at room temperature. Sections were then further incubated in diaminobenzidine (0.5 mg/mL, Sigma-Aldrich) and rinsed with TBS to stop the reaction. Tissue sections were mounted onto gelatine-coated slides and dehydrated through a series of alcohol baths. Images of each region of interest were taken using a microscope (Olympus) equipped with a digital camera. Quantifications were performed with ImageJ processing software and the number of positive cells per field was counted and averaged across three sections per animal, as previously described [11,53]. Counting was made twice by an investigator blinded to the identity of the samples and was expressed in cells/mm2.

2.6. Statistical Analysis

Statistical analyses were conducted via SigmaPlot 12.0 software, a scientific graphing and statistical analysis software package including normality and variance analyses. No statistical methods were used to predetermine the sample size. Normally distributed data were first tested for significance using Student’s t test prior to be analyzed by one- or -two way analysis of variance (ANOVA) followed by Neuwman–Keuls post-hoc test, when requested, as in our previous studies [5,11,12,54]. The initial sample size was N = 5 per group and was sometimes reduced to 4 for technical or unexpected concerns. For each ZT, first the ‘Group’ effect between control and experimental animals, treated with either cocaine or sucrose, was evaluated and secondly the ‘Time’ effect in control rats injected with saline or exposed to oral water intake. Significance was set at p < 0.05 and data are expressed as means ± S.E.M.

3. Results

3.1. Chronic Daily Cocaine and Sucrose Administration Does Not Affect Rat Body Weight

Sucrose reward has been reported to be a stronger reinforcer than cocaine in rodents, as sweetness can surpass cocaine reward, even in drug-sensitized individuals [55,56]. Daily administration for 10 days was performed by i.p. injection for cocaine or saline and by passive oral intake for sucrose and water and animals were sacrificed 5, 10, and 15 h after the last administration corresponding to Zeitgeber Time ZT6, ZT11, and ZT16 (Figure 1) for further daily analyses. Body weight was evaluated in the four groups (Supplementary Figure S2) and was found to vary from about 300 to 400 g during 10 days. At day one, no significant difference was observed between the lowest body weight group (passive water administration) and the highest body weight group (passive saline injections), both differing of 10%. Overall, the weight evolution curves from day 1 to day 10 remained similar in the four groups and at day 10 a difference of 11% was noticed between the same lowest and highest body weight groups, without significant difference. We therefore concluded that there is no relation between reward and body weight in our experimental conditions.

3.2. Cocaine and Sucrose Induce Opposite Effects on Dnmt3a and Dnmt3b in the PFCx and the CPu in a Time Dependent Manner

Among DNA methyltransferases (Dnmts) catalyzing the transfer of a methyl group predominantly at CpG dinucleotides to generate 5-methylcytosine (5mC), Dnmt3a and 3b are required for de novo DNA methylation [57] and are regulated by cocaine in various brain structures [10,11,14]. Their daily pattern of mRNA expression was measured by RT-qPCR in the PFCx and the CPu of rats following cocaine i.p. injection and sucrose oral administration (Figure 2). In the PFCx (Figure 2a,b), the expression of both Dnmts was only affected within the dark phase at ZT16. Indeed, both genes were found to be significantly repressed by cocaine and induced by sucrose intake at ZT16, while no significant effect of time was observed in either group of control rats. Likewise, an opposite pattern was observed in the CPu (Figure 2c,d), with Dnmt3a being inhibited by cocaine at ZT16, but induced earlier and transiently by sucrose intake at ZT6 and ZT11. Surprisingly, Dnmt3b was transiently induced by cocaine at ZT6, but its level progressively decreased leading to a repression at ZT16, whereas a progressive increase was found in response to sucrose intake (Figure 2d). In cocaine control rats, changes in the baseline levels of both genes were observed notably at ZT11 and ZT16 relative to ZT6 (Figure 2c,d), ZT16 being a time at which an increase was prevented by cocaine (Figure 2c,d). These changes are most likely to be due to the i.p. injections rather than changes in rhythmic expression, since they were not as significant in sucrose control rats after passive water administration. Therefore, an opposite regulation of Dnmt3a and 3b by cocaine and sucrose was observed at ZT16 during the rat active and nocturnal phase after the last administration at ZT1. This time-restricted modification in response to repeated cocaine administration appears consistent with previous kinetic studies having reported their daily variations or biphasic responses to the drug (Anier et al., 2010 [14]; LaPlant et al. [10], 2010; Pol Bodetto et al., 2013 [11]). We concluded that dynamic DNA methylation of Dnmt3 target sequences should be differentially methylated by a drug of abuse and a natural reinforcer at least at ZT16, even if no stable expression changes are observed over the day.

3.3. Daily Regulation of Tet 1, 2 and 3 Gene Expression by Cocaine and Sucrose

The discovery of Tet genes has demonstrated that cytosine methylation is a reversible and dynamic mechanism by which 5mC are oxidized into 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) prior to generate un-methylated cytosines [58,59] involving the base excision repair pathway [60]. In the PFCx and CPu, fewer differences were observed in Tet genes expression in response to both reinforcers especially at ZT16 (Figure 3), as compared with Dnmts. In the PFCx, both cocaine and sucrose transiently induced Tet 1 and 3 expression at ZT6, whereas no significant effect of time was noticed in either sucrose or cocaine control rats (Figure 3a,c). On the other hand, Tet 2 showed a significant rhythmic expression as ther highest levels were found during the dark phase at ZT16, in both control groups (Figure 3b). While Tet 2 expression was not at all affected by cocaine, it was progressively induced by sucrose intake, reaching the highest levels at ZT16. In the CPu, Tet 1 was repressed by sucrose at ZT6 and ZT16 but was not modified in response to cocaine. The two control groups did not show any rhythmic regulation (Figure 3d). In contrast, Tet 2 basal expression levels were increased at ZT11 in both control groups and this effect was magnified by sucrose, but not by cocaine (Figure 3e). Interestingly, its expression pattern in response to cocaine and sucrose was quite different relative to control levels. A transient repression at ZT6 followed by an induction at ZT16 was observed in response to cocaine, whereas a marked induction was only observed at ZT11 in response to sucrose. Tet 3 expression was not significantly affected by cocaine and sucrose in the CPu, but was solely increased by NaCl injection at ZT16 (Figure 3f).

3.4. Global 5-methylcytosines Analysis

Given the heterogeneous expression of Dnmt and Tet genes depending on the nature of the genes, the time, and the brain structure considered, we next measured global DNA methylation. The amount of 5mC produced by Dnmt before being oxidized by Tet proteins was evaluated in high molecular weight genomic DNA at ZT16 (Figure 4). In the PFCx and the CPu, a significant 5mC increase of 44% and 20%, respectively, was found in response to cocaine. In contrast, sucrose decreased the amount of 5mC by 30% and 23% in the PFCx and the CPu, respectively.

3.5. Effects of Cocaine and Sucrose on Clock and Clock-Controlled Gene Expression

Clock (Circadian Locomotor Output Cycles Kaput) encodes a transcription factor affecting both the persistence and period of circadian rhythms that orchestrate crucial physiological functions and daily behaviors. It dimerizes with Bmal1 (Brain and Muscle ARNT-like Protein-1) in order to activate other clock-controlled genes such as Period (Per1-3) and Crypto chromes (Cry1-2). Once translated and translocated into the nucleus, the period-cryptochrome protein complex displaces the Clock/Bmal1 heterodimers from chromatin, hence silencing Per and Cry genes through a transcriptional autoregulatory feedback loop [61]. In the PFCx, Clock expression was repressed by cocaine at ZT16 and by sucrose at ZT11. No rhythmic regulation was found in the sucrose control group, whereas its induction in cocaine control rats was likely due to NaCl i.p. injections and was prevented by cocaine (Figure 5a). The regulation of Bmal1 (Figure 5b), Per1 (Figure 5c) and Per2 (Figure 5d) genes by cocaine and sucrose was found to be different at least at one circadian time. Bmal1 was induced at ZT6 and repressed at ZT11 by cocaine, whereas it was only induced by sucrose at ZT16. A significant rhythmic regulation was observed in sucrose control group with a progressive decrease at ZT11 and ZT16. In contrast, NaCl injections induced its expression at ZT11 and ZT16, this induction was prevented by cocaine at ZT11. Per1 and Per2 were both repressed by cocaine at ZT16, whereas they were induced by sucrose at ZT6 and ZT16, respectively. A significant increased expression was observed for both Per genes along the day (Figure 5c,d), which was abolished by cocaine, whereas it was further pronounced for Per2 by sucrose at ZT16.
Similarly, in the CPu, clock gene expression was quite opposite in response to cocaine and sucrose administration relative to control rats (Figure 5e–h). In addition, while a significant rhythmic Bmal1 and Per1/2 expression was noticed in cocaine and sucrose control rats, cocaine was found to disrupt or to counteract it, whereas sucrose was found to further emphasize this periodic expression at some ZT (Figure 5f–h). This rhythmic expression is consistent with previous reports having shown a daily regulation by dopamine notably for Per genes in the dorsal striatum [62]. We therefore concluded that the two reinforcers markedly differ in regulating major circadian genes expression by their own relative to controls in both dopamine brain projections structures.

3.6. Cry1, Cry2, Rev-erbβ and Dbp1 Expression in Response to Cocaine and Sucrose

Additional Clock-controlled genes were next analyzed including Cry1, Cry2, Rev-erbβ, and Dbp1 (albumin D-element binding protein), the later transcription factor being often used as a molecular marker of circadian clock output [63]. In the PFCx, Cry1, Cry2, Rev-erbβ, and Dbp1 gene expression was found to be different in response to cocaine and sucrose at least at one ZT (Figure 6a–d). In sucrose control rats, only Dbp1 was found to have a significant rhythmic expression (Figure 6d), the rhythmic expression occasionally observed in cocaine control rats being likely due to the effect of saline i.p. injection [64]. In the CPu, Cry1 was repressed by both reinforcers at ZT16 (Figure 6e), while a moderate Cry2 repression was solely observed for cocaine at ZT6 (Figure 6f), both genes exhibiting a rhythmic expression. Rev-erbβ was upregulated by both cocaine and sucrose at ZT6 and ZT11, respectively (Figure 6g), whereas an opposite regulation was noticed for Dbp1 with a significant effect of time at ZT11 (Figure 6h). Overall, the two rewarding agents strongly differ in their effect on clock gene expression in both dopamine projection structures.

3.7. Neuropeptide Y and Orexin Regulation by Cocaine and Sucrose

Neuropeptide Y (Npy) is widely expressed throughout the central nervous system in which it is co-secreted with classic neurotransmitters, including GABA and glutamate [65]. It plays a crucial role in cortical excitability, stress response, food intake and circadian rhythms [66]. The Orexin gene has a more restricted expression pattern, being only transcribed in the lateral hypothalamus (LH), although we have provided evidence for orexin mRNA in the CPu, suggesting its transport from the LH [5]. Both Npy and orexin share common functions notably in the regulation of appetite and satiety and their receptors are considered as promising therapeutic targets for addictive behaviors and metabolic diseases [66]. In the PFCx cocaine and sucrose led to a consistent decrease in Npy mRNA expression at ZT11, without any significant effect of time in the corresponding control groups (Figure 7a). In contrast, the two control groups showed a significant upregulation at ZT11 and ZT16 in the CPu in which cocaine was preventing the time effect at ZT11, whereas Npy was solely induced by sucrose at ZT6 highlighting a reward agent specific response (Figure 7b). No effect of time was found for orexin mRNA levels in the CPu, suggesting that mRNA transport from the LH is not regulated in a time-of-day dependent manner. The transport was increased by cocaine at ZT16, whereas mRNA levels were much higher and striking compared with controls after sucrose administration at all time points (Figure 7c). Orx expression was further analyzed at ZT16 by IHC in the LH where it is synthesized (Figure 8). The number of Orx-positive cells was found to be higher in response to cocaine and lower in response to sucrose. The data therefore provide additional evidence concerning how the effects of a drug of abuse and a natural reinforcer differ in modulating genes at the protein level following repeated administrations.

3.8. Opposite Pattern of Per2 Positive Cells in Response to Sucrose and Cocaine in the LH

We next examined Per2 expression by IHC at ZT16 in the PFCx, the CPu, and the LH (Figure 9a–c). Strikingly, in all brain structures, the number of positive cells was lower in cocaine treated rats and higher in rats receiving sucrose relative to controls. It is noteworthy that the data parallel those obtained for mRNA in response to each reinforcer (Figure 4d,h). At higher magnification, Per2 cellular staining was diffuse with nuclear and cytosolic localization, consistent with previous reports [67]. The number of positive cells in NaCl i.p. injected rats was higher than that in rats receiving water orally (Figure 9), indicating that repeated injections by themselves also modulate Per2 expression, although these changes did not correlate with those found at the mRNA levels at ZT16 (Figure 4d,h). Nevertheless, that Per2 positive cells are down-regulated by cocaine and up-regulated by sucrose underlines some specific mechanisms different for each rewarding agent.

4. Discussion

The present study demonstrates that the response to cocaine and sucrose of many genes in dopamine projection areas and the hypothalamus is regulated in a time-dependent manner. While interactions between circadian rhythms and drugs of addiction within the mesocorticolimbic reward system have been reported previously [28,68,69,70], our findings show that a drug of abuse and a strong natural reinforcer in rodents trigger different changes in gene and protein expression in these brain areas. The genes and proteins investigated as part of mechanisms controlling DNA methylation, appetite, satiety, and circadian rhythms, underline that, depending on the reinforcer type, alterations in critical biological functions and their behavioral consequences are different. The current data further support initial fMRI and electrophysiological studies [1,2,3] and provide new insights into molecular and cellular mechanisms showing that the neural rewarding circuits activated by both reinforcers do not overlap.
Drugs of abuse and natural reinforcers can lead to addiction characterized as complex relapsing disorders occurring overtime in which compulsive seeking behavior can persist despite aversive consequences. Dopamine is known to play an essential role in the motivational aspect of reward and the dopamine theory of addiction highlights its major and common role in the mesolimbic system [71,72]. That is why we have looked at dopamine projection areas (PFCx and CPu), although drugs of abuse also sensitize noradrenergic and serotonergic neurons via non-dopaminergic mechanisms [6,69,73,74] and rewarding drugs, such as opiates or psychostimulants, induce different behavioral and neurobiological responses [75,76]. Developing pharmacological interventions specifically targeting dopamine receptors or its transporter system has also been reported to be a daunting task for the treatment of drugs of abuse [77]. Thus, the unitary account of addiction involving dopamine [76] has been challenged by several studies.
Here, we have compared chronic passive cocaine intake with that of sucrose since the latter is the main source of energy in the brain and a major component in highly palatable food. While sweetness has been reported to surpass cocaine reward in rodents [55], sugar addiction has been the subject of controversial issues [78,79]. Contrary to cocaine, little evidence has been provided for human sugar addiction or for a sugar addiction model of overweight to support clinical DSM criteria, suggesting that sugary food does not directly promote excessive weight or obesity, but rather contributes minimally to ‘food dependence’ and increased risk of weight gain by overeating [80,81]. By analyzing body weight development, no significant differences were found between cocaine and sucrose treated rats and their respective control groups (Supplementary Figure S2).
Overlap between drugs of abuse and natural reinforcers has been well illustrated by considering orexin, NPY, and ghrelin. Indeed, these peptides regulate appetite and satiety and their receptor antagonists have been characterized as promising therapeutic targets for addictive behaviors, drug abuse disorders, or metabolic diseases [38,39,40,65,82]. Orexinergic neurons widely project throughout the brain, including key structures of the limbic system, which are “multi-tasking” neurons regulating functions like arousal, sleep/wake states, feeding behavior, energy homeostasis, anxiety, and addictive behaviors. Orexin mRNA was induced by both cocaine and sucrose in the CPu although with a different timing (Figure 6c). In the LH, i.e., its site of transcription, the number of orexin positive cells was increased by cocaine but decreased by sucrose 15 h after the last administration (Figure 7, ZT16). This increase elicited by cocaine is in line with the upregulation of the number of LH orexin neurons after exposure to various drugs of abuse [83] and with the critical role of orexins in controlling arousal [84,85] and in the motivation for cocaine notably illustrated in Orx and Orx R1 knockdowns [37,86]. Moreover, it is noteworthy that the Orx R1 gene has been shown to be regulated by cocaine through DNA methylation [5].
Variations in Dnmt and Tet gene expression in response to reinforcers have been documented in various experimental models. Dnmts display biphasic time-course regulation following cocaine chronic passive treatment or in cocaine self-administering rats [5,10,11,14]. Tissue specific biological functions and specific target sequences have been reported for both gene families [87,88,89]. Our data concerning cocaine treatment are consistent with these studies, showing a heterogeneous pattern of expression depending not only on the brain structures, but also on the time of the day considered (Figure 2 and Figure 3). We also found a significant increase in global DNA methylation following cocaine administration and a decrease in response to sucrose in the PFCx and the CPu (Figure 4), while other global DNA methylation analyses have reported no or little changes in response to cocaine [33,34,36,90,91,92].
To some extent, chronic passive and voluntary drug intake cause similar behavioral and molecular effects. We therefore looked for differentially methylated regions (DMRs) associated with the 15 genes analyzed here from a genome-wide study performed in the PFCx of cocaine self-administering rats [36]. DMRs were found for 13 genes studied here, suggesting that they are regulated by DNA methylation. In agreement with previous global analyses, most DMRs were found within gene bodies for which no obvious correlation was established between 5mC hypermethylation and gene repression. Nevertheless, a single hypermethylated DMR was identified upstream at −2419 bp relative to the transcription start site of the Clock gene with a methylation ratio (cocaine)/(saline) of 1.44, that was repressed by 40% at ZT16. In addition, an upstream DMR at −2719 bp relative to the transcription start site of the Dbp1 gene was repressed by 52% at ZT11, while it was found to be hypermethylated with a 5mC ratio (cocaine)/(saline) of 1.18. The Cry2 gene that is repressed at ZT11 and ZT16 by 36 and 26%, respectively, was found to be hypermethylated in a downstream sequence with a 5mC ratio (cocaine)/(saline) of 1.75. Considering that cocaine and sucrose differentially regulate the expression of Dnmt and Tet genes (Figure 2 and Figure 3) as well as global DNA methylation (Figure 4) in the PFCx and the CPu, one may speculate that both agents consequently differ in modulating the rhythmicity of day/night cycles by altering gene expression resulting from chromatin modification in the brain.
While the role of orexins in the central and peripheral regulation of glucose homeostasis and metabolism has been reported, the effect of sugar on orexin expression or production has been less documented. Nevertheless, hypothalamic orexin neurons regulate arousal according to energy balance and a negative correlation was found between orexin expression and blood glucose and food intake [93]. Glucose was also reported to inhibit orexin neurons [94,95], and conversely, glucodeprivation was activating them [96]. In this respect, the decrease in orexin positive cells found in the LH following sucrose passive intake (Figure 7) further illustrates a marked difference relative to cocaine administration. In the CPu, sucrose was found to induce orexin mRNA levels (Figure 6c), which may sound surprising relative to the decreased orexin peptide expression in the LH (Figure 7). However, orexins display local brain structure-specific functions, so such differences may be attributed to different regulatory mechanisms between peptide exclusively transcribed in the LH and its mRNA transport to the CPu recently documented [5].
Unlike orexins, Npy neuropeptide is widely expressed throughout the central nervous system and secreted along with GABA and glutamate [65]. Because of its widespread distribution, including the peripheral nervous system, it is implicated in multiple physiological processes like cortical excitability, stress response, food intake, energy metabolism, memory, sleep regulation, and circadian rhythms [53]. While its regulation in the CNS has been studied extensively in the hippocampus and the hypothalamus, its expression in response to cocaine relative to sucrose has not yet been well investigated in the PFCx and CPu. In the PFCx, its baseline expression was not affected at any time, and it was solely repressed at ZT11 by both cocaine and sucrose (Figure 7a). This similar regulation suggests a common role of both reinforcers in NPY-mediated cortical cognitive functions such as short term/working or maintenance of memory, attention, and arousal. In the CPu, Npy showed a time-of-day dependence in both control groups (Figure 7b), indicating that, in this brain structure, unlike other genes, its expression is not solely affected by daily NaCl injections which may be associated with stress or pain [64] that can also affect DNA methylation in male rats notably following nerve injury [97].
As expected, analyzing all genes, independently of those only regulated by circadian rhythms, revealed a high number modulated by both reinforcers (Supplementary Figure S3). Indeed, most genes were induced by sucrose in the PFCx (10 out of 14) and in the CPu (10 out of 15), whereas most of them were repressed by cocaine in the PFCx (9 out of 14) and the CPu (8 out of 15). Hence, sucrose and cocaine strongly differ in the regulation of 11 out of 14 genes in the PFCx and 10 out of 15 in the CPu at least at one time point. The overall data further confirm earlier functional magnetic resonance imaging [1], as well as electrophysiological [3,16] and molecular studies [5,11] by showing that neural circuits activated by cocaine and natural reinforcers do not overlap.
In summary, our data highlight a discrepancy in the molecular and cellular mechanisms triggered by sucrose and cocaine in dopamine projection areas and in the hypothalamus. We previously reported that various genes were differentially affected by the voluntary administration of food vs. cocaine [5,11]. By analyzing key factors involved in DNA methylation, circadian rhythms, and appetite and satiety in passive intake, we provide new insights into marked differences in mechanisms occurring in the brain upon the administration of a drug of abuse or a natural reinforcer independently of the mode of administration. Whether the described cocaine-induced changes are long lasting remains to be investigated, but cocaine and non-natural reward were shown to produce persistent LTP in the VTA [98] and persistent variations in neuronal DNA methylation [99]. In addition, as recently reviewed, some studies have documented long-lasting changes in the expression of epigenetic enzymes and molecules that persist for weeks after the last drug exposure [100].
The regulation of DNA methylation factors by both agents raises questions regarding their common and tissue-specific target-methylated DNA sequences [88,101,102] and their role in the establishment and development of drug addiction. Cocaine alters the epigenome with potential consequences on future generations and de novo DNA methylation changes can be inherited in acquired or innate behaviors or diseases induced by environmental factors [14,103,104,105,106]. Understanding the mechanisms dissociating drugs of abuse from natural reinforcers is a prerequisite for the design of selective therapeutic tools to treat compulsive behaviors or addictions in the fascinating field of neuroepigenetics.

Supplementary Materials

The following are available online at www.mdpi.com/article/10.3390/genes12081195/s1, Figure S1: Dissected brain regions for mRNA analysis, Figure S2: Rat body weight during daily cocaine and sucrose administration, Figure S3: Overall gene regulation by sucrose and cocaine relative to controls.

Author Contributions

L.S. and P.A. preformed the experiments and created the figures; P.A., A.K. and J.Z. conceived the study; P.A. drafted the manuscript; A.K., L.S. and J.Z. revised the manuscript for final submission. The corresponding authors attest that all listed authors meet authorship criteria. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the CNRS and the Université de Strasbourg and Amsterdam (NIN&KNAW), by the Neurotime Erasmus Mundus + program of the European Commission including a doctoral fellowship attributed to L. Saad.

Institutional Review Board Statement

Sentences corresponding to ethical standards and approval involving animals are included within the Materials and methods section of the manuscript (first paragraph).

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Lu, H.; Chefer, S.; Kurup, P.K.; Guillem, K.; Vaupel, D.B.; Ross, T.J.; Moore, A.; Yang, Y.; Peoples, L.L.; Stein, E.A. fMRI response in the medial prefrontal cortex predicts cocaine but not sucrose self-administration history. Neuroimage 2012, 62, 1857–1866. [Google Scholar] [CrossRef] [Green Version]
  2. Levy, D.; Shabat-Simon, M.; Shalev, U.; Barnea-Ygael, N.; Cooper, A.; Zangen, A. Repeated electrical stimulation of reward-related brain regions affects cocaine but not “natural” reinforcement. J. Neurosci. 2007, 27, 14179–14189. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Cameron, C.M.; Wightman, R.M.; Carelli, R.M. Dynamics of rapid dopamine release in the nucleus accumbens during goal-directed behaviors for cocaine versus natural rewards. Neuropharmacology 2014, 86, 319–328. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Pol Bodetto, S.; Romieu, P.; Sartori, M.; Tesone-Coelho, C.; Majchrzak, M.; Barbelivien, A.; Zwiller, J.; Anglard, P. Differential regulation of MeCP2 and PP1 in passive or voluntary administration of cocaine or food. Int. J. Neuropsychopharmacol. 2014, 17, 2031–2044. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Saad, L.; Sartori, M.; Pol Bodetto, S.; Romieu, P.; Kalsbeek, A.; Zwiller, J.; Anglard, P. Regulation of Brain DNA Methylation Factors and of the Orexinergic System by Cocaine and Food Self-Administration. Mol. Neurobiol. 2019, 56, 5315–5331. [Google Scholar] [CrossRef] [Green Version]
  6. Cassel, S.; Carouge, D.; Gensburger, C.; Anglard, P.; Burgun, C.; Dietrich, J.B.; Aunis, D.; Zwiller, J. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol. Pharmacol. 2006, 70, 487–492. [Google Scholar] [CrossRef] [PubMed]
  7. Newton, S.S.; Duman, R.S. Chromatin remodeling: A novel mechanism of psychotropic drug action. Mol. Pharmacol. 2006, 70, 440–443. [Google Scholar] [CrossRef]
  8. Schenk, S.; Highgate, Q. Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse. J. Neurochem. 2021, 157, 1714–1724. [Google Scholar] [CrossRef]
  9. Good, K.V.; Vincent, J.B.; Ausio, J. MeCP2: The Genetic Driver of Rett Syndrome Epigenetics. Front. Genet. 2021, 12, 620859. [Google Scholar] [CrossRef]
  10. LaPlant, Q.; Vialou, V.; Covington, H.E., 3rd; Dumitriu, D.; Feng, J.; Warren, B.L.; Maze, I.; Dietz, D.M.; Watts, E.L.; Iniguez, S.D.; et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat. Neurosci. 2010, 13, 1137–1143. [Google Scholar] [CrossRef] [Green Version]
  11. Pol Bodetto, S.; Carouge, D.; Fonteneau, M.; Dietrich, J.B.; Zwiller, J.; Anglard, P. Cocaine represses protein phosphatase-1Cbeta through DNA methylation and Methyl-CpG Binding Protein-2 recruitment in adult rat brain. Neuropharmacology 2013, 73, 31–40. [Google Scholar] [CrossRef]
  12. Carouge, D.; Host, L.; Aunis, D.; Zwiller, J.; Anglard, P. CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol. Dis. 2010, 38, 414–424. [Google Scholar] [CrossRef] [PubMed]
  13. Amir, R.E.; Van den Veyver, I.B.; Wan, M.; Tran, C.Q.; Francke, U.; Zoghbi, H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23, 185–188. [Google Scholar] [CrossRef] [PubMed]
  14. Anier, K.; Malinovskaja, K.; Aonurm-Helm, A.; Zharkovsky, A.; Kalda, A. DNA methylation regulates cocaine-induced behavioral sensitization in mice. Neuropsychopharmacology 2010, 35, 2450–2461. [Google Scholar] [CrossRef] [Green Version]
  15. Ploense, K.L.; Li, X.; Baker-Andresen, D.; Carr, A.E.; Woodward, N.; Bagley, J.; Szumlinski, K.K.; Bredy, T.W.; Kippin, T.E. Prolonged-access to cocaine induces distinct Homer2 DNA methylation, hydroxymethylation, and transcriptional profiles in the dorsomedial prefrontal cortex of Male Sprague-Dawley rats. Neuropharmacology 2018, 143, 299–305. [Google Scholar] [CrossRef] [Green Version]
  16. Levy, K.A.; Brodnik, Z.D.; Shaw, J.K.; Perrey, D.A.; Zhang, Y.; Espana, R.A. Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling. Psychopharmacology 2017, 234, 2761–2776. [Google Scholar] [CrossRef] [PubMed]
  17. Sadri-Vakili, G. Cocaine triggers epigenetic alterations in the corticostriatal circuit. Brain Res. 2015, 1628, 50–59. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Cadet, J.L. Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications. Mol. Neurobiol. 2016, 53, 545–560. [Google Scholar] [CrossRef] [Green Version]
  19. Vaillancourt, K.; Ernst, C.; Mash, D.; Turecki, G. DNA Methylation Dynamics and Cocaine in the Brain: Progress and Prospects. Genes 2017, 8, 138. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Anglard, P.; Zwiller, J. Cocaine and Epigenetics: An Overview. Book Chapter in the Neuroscience of Cocaine: Mechanisms and Treatment; Elsevier: Amsterdam, The Netherlands; Academic Press: Cambridge, MA, USA, 2017; pp. 79–88. [Google Scholar]
  21. Campbell, R.R.; Wood, M.A. How the epigenome integrates information and reshapes the synapse. Nat. Rev. Neurosci. 2019, 20, 133–147. [Google Scholar] [CrossRef]
  22. Coulson, R.L.; LaSalle, J.M. Epigenetics of Circadian Rhythms in Imprinted Neurodevelopmental Disorders. Prog. Mol. Biol. Transl. Sci. 2018, 157, 67–92. [Google Scholar]
  23. Kadayifci, F.Z.; Zheng, S.; Pan, Y.X. Molecular Mechanisms Underlying the Link between Diet and DNA Methylation. Int. J. Mol. Sci. 2018, 19, 4055. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Luo, C.; Hajkova, P.; Ecker, J.R. Dynamic DNA methylation: In the right place at the right time. Science 2018, 361, 1336–1340. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Albrecht, U. The circadian clock, reward, and memory. Front. Mol. Neurosci 2011, 4, 41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Jansen, H.T.; Sergeeva, A.; Stark, G.; Sorg, B.A. Circadian discrimination of reward: Evidence for simultaneous yet separable food- and drug-entrained rhythms in the rat. Chronobiol. Int. 2012, 29, 454–468. [Google Scholar] [CrossRef] [PubMed]
  27. Abarca, C.; Albrecht, U.; Spanagel, R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc. Natl. Acad. Sci. USA 2002, 99, 9026–9030. [Google Scholar] [CrossRef] [Green Version]
  28. Stowie, A.C.; Amicarelli, M.J.; Prosser, R.A.; Glass, J.D. Chronic cocaine causes long-term alterations in circadian period and photic entrainment in the mouse. Neuroscience 2015, 284, 171–179. [Google Scholar] [CrossRef]
  29. Prosser, R.A.; Stowie, A.; Amicarelli, M.; Nackenoff, A.G.; Blakely, R.D.; Glass, J.D. Cocaine modulates mammalian circadian clock timing by decreasing serotonin transport in the SCN. Neuroscience 2014, 275, 184–193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Prosser, R.A.; Glass, J.D. Neurological aspects of cocaine and the suprachiasmatic circadian clock. In Book Chapter in the Neuroscience of Cocaine: Mechanisms and Treatment; Elsevier: Amsterdam, The Netherlands; Academic Press: Cambridge, MA, USA, 2017; pp. 163–172. [Google Scholar] [CrossRef]
  31. Joska, T.M.; Zaman, R.; Belden, W.J. Regulated DNA methylation and the circadian clock: Implications in cancer. Biology 2014, 3, 560–577. [Google Scholar] [CrossRef] [Green Version]
  32. Azzi, A.; Evans, J.A.; Leise, T.; Myung, J.; Takumi, T.; Davidson, A.J.; Brown, S.A. Network Dynamics Mediate Circadian Clock Plasticity. Neuron 2017, 93, 441–450. [Google Scholar] [CrossRef] [Green Version]
  33. Tian, W.; Zhao, M.; Li, M.; Song, T.; Zhang, M.; Quan, L.; Li, S.; Sun, Z.S. Reversal of cocaine-conditioned place preference through methyl supplementation in mice: Altering global DNA methylation in the prefrontal cortex. PLoS ONE 2012, 7, e33435. [Google Scholar] [CrossRef]
  34. Wright, K.N.; Hollis, F.; Duclot, F.; Dossat, A.M.; Strong, C.E.; Francis, T.C.; Mercer, R.; Feng, J.; Dietz, D.M.; Lobo, M.K.; et al. Methyl supplementation attenuates cocaine-seeking behaviors and cocaine-induced c-Fos activation in a DNA methylation-dependent manner. J. Neurosci. 2015, 35, 8948–8958. [Google Scholar] [CrossRef] [PubMed]
  35. Anier, K.; Zharkovsky, A.; Kalda, A. S-adenosylmethionine modifies cocaine-induced DNA methylation and increases locomotor sensitization in mice. Int. J. Neuropsychopharmacol. 2013, 16, 2053–2066. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Fonteneau, M.; Filliol, D.; Anglard, P.; Befort, K.; Romieu, P.; Zwiller, J. Inhibition of DNA methyltransferases regulates cocaine self-administration by rats: A genome-wide DNA methylation study. Genes Brain Behav. 2017, 16, 313–327. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Schmeichel, B.E.; Matzeu, A.; Koebel, P.; Vendruscolo, L.F.; Sidhu, H.; Shahryari, R.; Kieffer, B.L.; Koob, G.F.; Martin-Fardon, R.; Contet, C. Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats. Neuropsychopharmacology 2018, 43, 2373–2382. [Google Scholar] [CrossRef] [Green Version]
  38. Boutrel, B.; Steiner, N.; Halfon, O. The hypocretins and the reward function: What have we learned so far? Front. Behav. Neurosci. 2013, 7, 59. [Google Scholar] [CrossRef] [Green Version]
  39. Gentile, T.A.; Simmons, S.J.; Barker, D.J.; Shaw, J.K.; Espana, R.A.; Muschamp, J.W. Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addict. Biol. 2017, 23, 247–255. [Google Scholar] [CrossRef] [Green Version]
  40. Wiskerke, J.; James, M.H.; Aston-Jones, G. The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task. Brain Res. 2019, 1731, 146222. [Google Scholar] [CrossRef]
  41. Rotter, A.; Bayerlein, K.; Hansbauer, M.; Weiland, J.; Sperling, W.; Kornhuber, J.; Biermann, T. Orexin A expression and promoter methylation in patients with cannabis dependence in comparison to nicotine-dependent cigarette smokers and nonsmokers. Neuropsychobiology 2012, 66, 126–133. [Google Scholar] [CrossRef] [Green Version]
  42. Hayakawa, K.; Hirosawa, M.; Tabei, Y.; Arai, D.; Tanaka, S.; Murakami, N.; Yagi, S.; Shiota, K. Epigenetic switching by the metabolism-sensing factors in the generation of orexin neurons from mouse embryonic stem cells. J. Biol. Chem. 2013, 288, 17099–17110. [Google Scholar] [CrossRef] [Green Version]
  43. Dehan, P.; Canon, C.; Trooskens, G.; Rehli, M.; Munaut, C.; Van Criekinge, W.; Delvenne, P. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer. J. Clin. Endocrinol. Metab. 2013, 98, 1549–1557. [Google Scholar] [CrossRef] [Green Version]
  44. Boersma, G.J.; Liang, N.C.; Lee, R.S.; Albertz, J.D.; Kastelein, A.; Moody, L.A.; Aryal, S.; Moran, T.H.; Tamashiro, K.L. Failure to upregulate Agrp and Orexin in response to activity based anorexia in weight loss vulnerable rats characterized by passive stress coping and prenatal stress experience. Psychoneuroendocrinology 2016, 67, 171–181. [Google Scholar] [CrossRef] [Green Version]
  45. James, M.H.; Stopper, C.M.; Zimmer, B.A.; Koll, N.E.; Bowrey, H.E.; Aston-Jones, G. Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats. Biol. Psychiatry 2018, 85, 925–935. [Google Scholar] [CrossRef]
  46. Anglard, P.; Tory, K.; Brauch, H.; Weiss, G.H.; Latif, F.; Merino, M.J.; Lerman, M.I.; Zbar, B.; Linehan, W.M. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res. 1991, 51, 1071–1077. [Google Scholar]
  47. Nugent, B.M.; Wright, C.L.; Shetty, A.C.; Hodes, G.E.; Lenz, K.M.; Mahurkar, A.; Russo, S.J.; Devine, S.E.; McCarthy, M.M. Brain feminization requires active repression of masculinization via DNA methylation. Nat. Neurosci. 2015, 18, 690–697. [Google Scholar] [CrossRef] [Green Version]
  48. Feillet, C.A.; Bainier, C.; Mateo, M.; Blancas-Velazquez, A.; Salaberry, N.L.; Ripperger, J.A.; Albrecht, U.; Mendoza, J. Rev-erbalpha modulates the hypothalamic orexinergic system to influence pleasurable feeding behaviour in mice. Addict. Biol. 2017, 22, 411–422. [Google Scholar] [CrossRef]
  49. LeSauter, J.; Lambert, C.M.; Robotham, M.R.; Model, Z.; Silver, R.; Weaver, D.R. Antibodies for assessing circadian clock proteins in the rodent suprachiasmatic nucleus. PLoS ONE 2012, 7, e35938. [Google Scholar] [CrossRef] [Green Version]
  50. Evans, J.A.; Suen, T.C.; Callif, B.L.; Mitchell, A.S.; Castanon-Cervantes, O.; Baker, K.M.; Kloehn, I.; Baba, K.; Teubner, B.J.; Ehlen, J.C.; et al. Shell neurons of the master circadian clock coordinate the phase of tissue clocks throughout the brain and body. BMC Biol. 2015, 13, 43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Ozek, C.; Krolewski, R.C.; Buchanan, S.M.; Rubin, L.L. Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice. Sci. Rep. 2018, 8, 17293. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Gajewski, P.A.; Eagle, A.L.; Williams, E.S.; Manning, C.E.; Lynch, H.; McCornack, C.; Maze, I.; Heller, E.A.; Robison, A.J. Epigenetic Regulation of Hippocampal Fosb Expression Controls Behavioral Responses to Cocaine. J. Neurosci. 2019, 39, 8305–8314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Yi, C.X.; Serlie, M.J.; Ackermans, M.T.; Foppen, E.; Buijs, R.M.; Sauerwein, H.P.; Fliers, E.; Kalsbeek, A. A major role for perifornical orexin neurons in the control of glucose metabolism in rats. Diabetes 2009, 58, 1998–2005. [Google Scholar] [CrossRef] [Green Version]
  54. Oak, M.H.; El Bedoui, J.; Anglard, P.; Schini-Kerth, V.B. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Circulation 2004, 110, 1861–1867. [Google Scholar] [CrossRef] [Green Version]
  55. Lenoir, M.; Serre, F.; Cantin, L.; Ahmed, S.H. Intense sweetness surpasses cocaine reward. PLoS ONE 2007, 2, e698. [Google Scholar] [CrossRef] [Green Version]
  56. Vanhille, N.; Belin-Rauscent, A.; Mar, A.C.; Ducret, E.; Belin, D. High locomotor reactivity to novelty is associated with an increased propensity to choose saccharin over cocaine: New insights into the vulnerability to addiction. Neuropsychopharmacology 2015, 40, 577–589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Goll, M.G.; Bestor, T.H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 2005, 74, 481–514. [Google Scholar] [CrossRef] [Green Version]
  58. Tahiliani, M.; Koh, K.P.; Shen, Y.; Pastor, W.A.; Bandukwala, H.; Brudno, Y.; Agarwal, S.; Iyer, L.M.; Liu, D.R.; Aravind, L.; et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324, 930–935. [Google Scholar] [CrossRef] [Green Version]
  59. Ito, S.; Shen, L.; Dai, Q.; Wu, S.C.; Collins, L.B.; Swenberg, J.A.; He, C.; Zhang, Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333, 1300–1303. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Wilson, D.M., 3rd; Kim, D.; Berquist, B.R.; Sigurdson, A.J. Variation in base excision repair capacity. Mutat. Res. 2011, 711, 100–112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Pacheco-Bernal, I.; Becerril-Perez, F.; Aguilar-Arnal, L. Circadian rhythms in the three-dimensional genome: Implications of chromatin interactions for cyclic transcription. Clin. Epigenetics 2019, 11, 79. [Google Scholar] [CrossRef]
  62. Hood, S.; Cassidy, P.; Cossette, M.P.; Weigl, Y.; Verwey, M.; Robinson, B.; Stewart, J.; Amir, S. Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J. Neurosci. 2010, 30, 14046–14058. [Google Scholar] [CrossRef]
  63. Ripperger, J.A.; Shearman, L.P.; Reppert, S.M.; Schibler, U. CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes Dev. 2000, 14, 679–689. [Google Scholar]
  64. Slamberova, R.; Nohejlova, K.; Ochozkova, A.; Mihalcikova, L. What is the role of subcutaneous single injections on the behavior of adult male rats exposed to drugs? Physiol. Res. 2018, 67, S665–S672. [Google Scholar] [CrossRef]
  65. Robinson, S.L.; Thiele, T.E. The Role of Neuropeptide Y (NPY) in Alcohol and Drug Abuse Disorders. Int. Rev. Neurobiol. 2017, 136, 177–197. [Google Scholar] [PubMed]
  66. Yi, M.; Li, H.; Wu, Z.; Yan, J.; Liu, Q.; Ou, C.; Chen, M. A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans. Cell Physiol. Biochem. 2018, 45, 88–107. [Google Scholar] [CrossRef]
  67. Field, M.D.; Maywood, E.S.; O’Brien, J.A.; Weaver, D.R.; Reppert, S.M.; Hastings, M.H. Analysis of clock proteins in mouse SCN demonstrates phylogenetic divergence of the circadian clockwork and resetting mechanisms. Neuron 2000, 25, 437–447. [Google Scholar] [CrossRef] [Green Version]
  68. Perreau-Lenz, S.; Spanagel, R. Clock genes x stress x reward interactions in alcohol and substance use disorders. Alcohol 2015, 49, 351–357. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Uz, T.; Ahmed, R.; Akhisaroglu, M.; Kurtuncu, M.; Imbesi, M.; Dirim Arslan, A.; Manev, H. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience 2005, 134, 1309–1316. [Google Scholar] [CrossRef]
  70. Lynch, W.J.; Girgenti, M.J.; Breslin, F.J.; Newton, S.S.; Taylor, J.R. Gene profiling the response to repeated cocaine self-administration in dorsal striatum: A focus on circadian genes. Brain Res. 2008, 1213, 166–177. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Wise, R.A.; Bozarth, M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 1987, 94, 469–492. [Google Scholar] [CrossRef]
  72. Di Chiara, G.; Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 1988, 85, 5274–5278. [Google Scholar] [CrossRef] [Green Version]
  73. Lanteri, C.; Salomon, L.; Torrens, Y.; Glowinski, J.; Tassin, J.P. Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism. Neuropsychopharmacology 2008, 33, 1724–1734. [Google Scholar] [CrossRef] [Green Version]
  74. De Backer, J.F.; Monlezun, S.; Detraux, B.; Gazan, A.; Vanopdenbosch, L.; Cheron, J.; Cannazza, G.; Valverde, S.; Cantacorps, L.; Nassar, M.; et al. Deletion of Maged1 in mice abolishes locomotor and reinforcing effects of cocaine. EMBO Rep. 2018, 19, e45089. [Google Scholar] [CrossRef]
  75. Badiani, A.; Belin, D.; Epstein, D.; Calu, D.; Shaham, Y. Opiate versus psychostimulant addiction: The differences do matter. Nat. Rev. Neurosci. 2013, 12, 685–700. [Google Scholar] [CrossRef]
  76. Nutt, D.J.; Lingford-Hughes, A.; Erritzoe, D.; Stokes, P.R. The dopamine theory of addiction: 40 years of highs and lows. Nat. Rev. Neurosci. 2015, 16, 305–312. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Hansson, A.C.; Grunder, G.; Hirth, N.; Noori, H.R.; Spanagel, R.; Sommer, W.H. Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies. Neurosci. Biobehav. Rev. 2019, 106, 141–164. [Google Scholar] [CrossRef]
  78. DiNicolantonio, J.J.; O’Keefe, J.H.; Wilson, W.L. Sugar addiction: Is it real? A narrative review. Br. J. Sports Med. 2017, 52, 910–913. [Google Scholar] [CrossRef]
  79. Wei, S.; Bilbao, R.; Spanagel, R. Sugar-addictive phenotypes in mice. Eur. Neuropsychopharmacol. 2018, 25, S23–S24. [Google Scholar] [CrossRef]
  80. Westwater, M.L.; Fletcher, P.C.; Ziauddeen, H. Sugar addiction: The state of the science. Eur. J. Nutr. 2016, 55, 55–69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  81. Markus, C.R.; Rogers, P.J.; Brouns, F.; Schepers, R. Eating dependence and weight gain; no human evidence for a ’sugar-addiction’ model of overweight. Appetite 2017, 114, 64–72. [Google Scholar] [CrossRef] [Green Version]
  82. Sorensen, G.; Wortwein, G.; Fink-Jensen, A.; Woldbye, D.P. Neuropeptide Y Y5 receptor antagonism causes faster extinction and attenuates reinstatement in cocaine-induced place preference. Pharmacol. Biochem. Behav. 2013, 105, 151–156. [Google Scholar] [CrossRef]
  83. Pantazis, C.B.; James, M.H.; Bentzley, B.S.; Aston-Jones, G. The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand. Addict. Biol. 2019, 25, e12795. [Google Scholar] [CrossRef] [PubMed]
  84. Calipari, E.S.; Espana, R.A. Hypocretin/orexin regulation of dopamine signaling: Implications for reward and reinforcement mechanisms. Front. Behav. Neurosci. 2012, 6, 54. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Alexandre, C.; Andermann, M.L.; Scammell, T.E. Control of arousal by the orexin neurons. Curr. Opin. Neurobiol. 2013, 23, 752–759. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Bernstein, D.L.; Badve, P.S.; Barson, J.R.; Bass, C.E.; Espana, R.A. Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine. Addict. Biol. 2018, 23, 1032–1045. [Google Scholar] [CrossRef]
  87. Tan, L.; Shi, Y.G. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 2012, 139, 1895–1902. [Google Scholar] [CrossRef] [Green Version]
  88. Rasmussen, K.D.; Helin, K. Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev. 2016, 30, 733–750. [Google Scholar] [CrossRef]
  89. Chen, Z.X.; Riggs, A.D. DNA methylation and demethylation in mammals. J. Biol. Chem. 2011, 286, 18347–18353. [Google Scholar] [CrossRef] [Green Version]
  90. Fragou, D.; Zanos, P.; Kouidou, S.; Njau, S.; Kitchen, I.; Bailey, A.; Kovatsi, L. Effect of chronic heroin and cocaine administration on global DNA methylation in brain and liver. Toxicol. Lett. 2013, 218, 260–265. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  91. Feng, J.; Shao, N.; Szulwach, K.E.; Vialou, V.; Huynh, J.; Zhong, C.; Le, T.; Ferguson, D.; Cahill, M.E.; Li, Y.; et al. Role of Tet1 and 5-hydroxymethylcytosine in cocaine action. Nat. Neurosci. 2015, 18, 536–544. [Google Scholar] [CrossRef] [PubMed]
  92. Massart, R.; Barnea, R.; Dikshtein, Y.; Suderman, M.; Meir, O.; Hallett, M.; Kennedy, P.; Nestler, E.J.; Szyf, M.; Yadid, G. Role of DNA methylation in the nucleus accumbens in incubation of cocaine craving. J. Neurosci. 2015, 35, 8042–8058. [Google Scholar] [CrossRef] [Green Version]
  93. Yamanaka, A.; Beuckmann, C.T.; Willie, J.T.; Hara, J.; Tsujino, N.; Mieda, M.; Tominaga, M.; Yagami, K.; Sugiyama, F.; Goto, K.; et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38, 701–713. [Google Scholar] [CrossRef] [Green Version]
  94. Burdakov, D.; Jensen, L.T.; Alexopoulos, H.; Williams, R.H.; Fearon, I.M.; O’Kelly, I.; Gerasimenko, O.; Fugger, L.; Verkhratsky, A. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron 2006, 50, 711–722. [Google Scholar] [CrossRef]
  95. Sheng, Z.; Santiago, A.M.; Thomas, M.P.; Routh, V.H. Metabolic regulation of lateral hypothalamic glucose-inhibited orexin neurons may influence midbrain reward neurocircuitry. Mol. Cell Neurosci. 2014, 62, 30–41. [Google Scholar] [CrossRef] [PubMed]
  96. Li, A.J.; Wang, Q.; Elsarelli, M.M.; Brown, R.L.; Ritter, S. Hindbrain Catecholamine Neurons Activate Orexin Neurons During Systemic Glucoprivation in Male Rats. Endocrinology 2015, 156, 2807–2820. [Google Scholar] [CrossRef]
  97. Franco-Enzastiga, U.; Garcia, G.; Murbartian, J.; Gonzalez-Barrios, R.; Salinas-Abarca, A.B.; Sanchez-Hernandez, B.; Tavares-Ferreira, D.; Herrera, L.A.; Barragan-Iglesias, P.; Delgado-Lezama, R.; et al. Sex-dependent pronociceptive role of spinal alpha5 -GABAA receptor and its epigenetic regulation in neuropathic rodents. J. Neurochem. 2020, 156, 897–916. [Google Scholar] [CrossRef]
  98. Chen, B.T.; Bowers, M.S.; Martin, M.; Hopf, F.W.; Guillory, A.M.; Carelli, R.M.; Chou, J.K.; Bonci, A. Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron 2008, 59, 288–297. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Baker-Andresen, D.; Zhao, Q.; Li, X.; Jupp, B.; Chesworth, R.; Lawrence, A.J.; Bredy, T. Persistent variations in neuronal DNA methylation following cocaine self-administration and protracted abstinence in mice. Neuroepigenetics 2015, 4, 1–11. [Google Scholar] [CrossRef] [Green Version]
  100. Werner, C.T.; Altshuler, R.D.; Shaham, Y.; Li, X. Epigenetic Mechanisms in Drug Relapse. Biol. Psychiatry 2020, 14, 341–350. [Google Scholar] [CrossRef] [PubMed]
  101. Challen, G.A.; Sun, D.; Mayle, A.; Jeong, M.; Luo, M.; Rodriguez, B.; Mallaney, C.; Celik, H.; Yang, L.; Xia, Z.; et al. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell 2014, 15, 350–364. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Liao, J.; Karnik, R.; Gu, H.; Ziller, M.J.; Clement, K.; Tsankov, A.M.; Akopian, V.; Gifford, C.A.; Donaghey, J.; Galonska, C.; et al. Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells. Nat. Genet. 2015, 47, 469–478. [Google Scholar] [CrossRef] [Green Version]
  103. Gonzalez, B.; Pantoja, C.R.G.; Sosa, M.H.; Vitullo, A.D.; Bisagno, V.; Gonzalez, C.R. Cocaine alters the mouse testicular epigenome with direct impact on histone acetylation and DNA methylation marks. Reprod. Biomed. Online 2018, 37, 269–278. [Google Scholar] [CrossRef] [PubMed]
  104. Nilsson, E.E.; Sadler-Riggleman, I.; Skinner, M.K. Environmentally induced epigenetic transgenerational inheritance of disease. Environ. Epigenet. 2018, 4, dvy016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Lazar-Contes, I.; Roszkowski, M.; Tanwar, D.K.; Mansuy, I.M. Symposium summary: Epigenetic inheritance-impact for biology and society 26-28 August 2019, Zurich, Switzerland. Environ. Epigenet 2020, 6, dvaa004. [Google Scholar] [CrossRef] [PubMed]
  106. Geoffroy, A.; Kerek, R.; Pourie, G.; Helle, D.; Gueant, J.L.; Daval, J.L.; Bossenmeyer-Pourie, C. Late Maternal Folate Supplementation Rescues from Methyl Donor Deficiency-Associated Brain Defects by Restoring Let-7 and miR-34 Pathways. Mol. Neurobiol. 2017, 54, 5017–5033. [Google Scholar] [CrossRef]
Genes 12 01195 g001 550
Figure 1. Chronic daily administration of cocaine and sucrose. Daily cocaine and sucrose administration was performed for 10 days at 8 am, 1 h after the beginning of the light phase ranging from Zeitgeber Time 0 (ZT0) = lights on to ZT12 = lights off. After 10 days, rats were sacrificed 5 h, 10 h and 15 h after the last administration at the indicated time denoted as ZT (6, 11 and 16) or time of the day. Zeitgeber time (ZT) is a standardized 24-h notation in which ZT0 indicates the beginning of the light phase and ZT12 is the beginning of the dark phase.
Figure 1. Chronic daily administration of cocaine and sucrose. Daily cocaine and sucrose administration was performed for 10 days at 8 am, 1 h after the beginning of the light phase ranging from Zeitgeber Time 0 (ZT0) = lights on to ZT12 = lights off. After 10 days, rats were sacrificed 5 h, 10 h and 15 h after the last administration at the indicated time denoted as ZT (6, 11 and 16) or time of the day. Zeitgeber time (ZT) is a standardized 24-h notation in which ZT0 indicates the beginning of the light phase and ZT12 is the beginning of the dark phase.
Genes 12 01195 g001
Genes 12 01195 g002 550
Figure 2. Relative Dnmt3a and Dnmt3b mRNA expression in the PFCx and the CPu in response to passive cocaine and sucrose intake. Cocaine and sucrose delivery was analyzed in the PFCx (a,b) and in the CPu (c,d) by quantitative RT-PCR 5 h, 10 h and 15 h after the last administration, as indicated (corresponding to ZT 6, ZT 11 and ZT 16). Dnmt3a expression in the PFCx (a) and in the CPu (c) was compared with that of Dnmt3b in the same brain structures (b,d), respectively. The amount of each transcript was normalized to that of 36B4. Data represent the mean ± SEM, n = 4–5 per group. Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc when required. Significant differences between control and treated groups and within control groups relative to ZT 6 are indicated. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 2. Relative Dnmt3a and Dnmt3b mRNA expression in the PFCx and the CPu in response to passive cocaine and sucrose intake. Cocaine and sucrose delivery was analyzed in the PFCx (a,b) and in the CPu (c,d) by quantitative RT-PCR 5 h, 10 h and 15 h after the last administration, as indicated (corresponding to ZT 6, ZT 11 and ZT 16). Dnmt3a expression in the PFCx (a) and in the CPu (c) was compared with that of Dnmt3b in the same brain structures (b,d), respectively. The amount of each transcript was normalized to that of 36B4. Data represent the mean ± SEM, n = 4–5 per group. Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc when required. Significant differences between control and treated groups and within control groups relative to ZT 6 are indicated. * p < 0.05, ** p < 0.01, *** p < 0.001.
Genes 12 01195 g002
Genes 12 01195 g003 550
Figure 3. Tet 1,2 and 3 mRNA expression in the PFCx and in the CPu in response to cocaine and sucrose intake. Relative Tet 1, 2 and 3 gene expression was analyzed in the PFCx (a–c) and in the CPu (d–f) after the last passive administration at various times corresponding to ZT illustrated in Figure 1. Data represent the mean ± SEM, n = 4–5 per group. Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc test when required. Significant differences between control and treated groups and within control groups relative to ZT 6 (5 h after administration) are indicated. * p < 0.05, ** p < 0.01.
Figure 3. Tet 1,2 and 3 mRNA expression in the PFCx and in the CPu in response to cocaine and sucrose intake. Relative Tet 1, 2 and 3 gene expression was analyzed in the PFCx (a–c) and in the CPu (d–f) after the last passive administration at various times corresponding to ZT illustrated in Figure 1. Data represent the mean ± SEM, n = 4–5 per group. Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc test when required. Significant differences between control and treated groups and within control groups relative to ZT 6 (5 h after administration) are indicated. * p < 0.05, ** p < 0.01.
Genes 12 01195 g003
Genes 12 01195 g004 550
Figure 4. Global 5-methylcytosine analysis in the PFCx and in the CPu. 5mC was measured in response to cocaine and sucrose relative to their controls at ZT16 (15 h after administration). Data represent the mean ± SEM, n = 4 per group. Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc when required. * p < 0.05, ** p < 0.01.
Figure 4. Global 5-methylcytosine analysis in the PFCx and in the CPu. 5mC was measured in response to cocaine and sucrose relative to their controls at ZT16 (15 h after administration). Data represent the mean ± SEM, n = 4 per group. Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc when required. * p < 0.05, ** p < 0.01.
Genes 12 01195 g004
Genes 12 01195 g005 550
Figure 5. Clock, Bmal1, Per1 and Per2 gene expression in the PFCx and the CPu (a,b,d–f,h). Relative mRNA levels (c,g) of circadian genes were analyzed as described in Figure 3. Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc test when required. Significant differences between control and treated groups and within control groups relative to ZT 6 (5 h after administration) are also indicated with n = 4–5 per group. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 5. Clock, Bmal1, Per1 and Per2 gene expression in the PFCx and the CPu (a,b,d–f,h). Relative mRNA levels (c,g) of circadian genes were analyzed as described in Figure 3. Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc test when required. Significant differences between control and treated groups and within control groups relative to ZT 6 (5 h after administration) are also indicated with n = 4–5 per group. * p < 0.05, ** p < 0.01, *** p < 0.001.
Genes 12 01195 g005
Genes 12 01195 g006 550
Figure 6. Cry1, Cry2, Rev-erbβ and Dbp1 mRNA levels in the PFCx and the CPu (a,b,d–f,h). Relative mRNA levels (c,g) of the 4 genes and statistical analyses were performed, as described in legend to Figure 2. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 6. Cry1, Cry2, Rev-erbβ and Dbp1 mRNA levels in the PFCx and the CPu (a,b,d–f,h). Relative mRNA levels (c,g) of the 4 genes and statistical analyses were performed, as described in legend to Figure 2. * p < 0.05, ** p < 0.01, *** p < 0.001.
Genes 12 01195 g006
Genes 12 01195 g007 550
Figure 7. NPY and orexin neuropeptides mRNA levels in the PFCx and the CPu. Relative expression of mRNAs was analyzed(a–c), as described in legend to Figure 2. * p < 0.01, ** p < 0.01, *** p < 0.001.
Figure 7. NPY and orexin neuropeptides mRNA levels in the PFCx and the CPu. Relative expression of mRNAs was analyzed(a–c), as described in legend to Figure 2. * p < 0.01, ** p < 0.01, *** p < 0.001.
Genes 12 01195 g007
Genes 12 01195 g008 550
Figure 8. Effect of passive administration of cocaine or sucrose on orexin peptide in the lateral hypothalamus by IHC. Quantification and photomicrographs showing orexin immunoreactivity at ZT 16 in the LH of rats treated daily for 10 days with saline or 20 mg/kg cocaine (one i.p. injection per day) or with sucrose (10 days, one oral administration per day). Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc test. Significant differences are indicated with n = 4–5 per group. * p < 0.05, ** p < 0.01. Scale bar, 200 µm.
Figure 8. Effect of passive administration of cocaine or sucrose on orexin peptide in the lateral hypothalamus by IHC. Quantification and photomicrographs showing orexin immunoreactivity at ZT 16 in the LH of rats treated daily for 10 days with saline or 20 mg/kg cocaine (one i.p. injection per day) or with sucrose (10 days, one oral administration per day). Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc test. Significant differences are indicated with n = 4–5 per group. * p < 0.05, ** p < 0.01. Scale bar, 200 µm.
Genes 12 01195 g008
Genes 12 01195 g009 550
Figure 9. Per2 analysis by IHC in response to passive cocaine and sucrose administration. Quantification and photomicrographs showing Per2 immunoreactivity in the PFCx, CPu and LH of rats treated daily for 10 days with saline or 20 mg/kg cocaine (one i.p. injection per day) and with sucrose (one administration per day) (a–c). Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc test. Significant differences are indicated with n = 4–5 per group. ** p < 0.01, *** p < 0.001.
Figure 9. Per2 analysis by IHC in response to passive cocaine and sucrose administration. Quantification and photomicrographs showing Per2 immunoreactivity in the PFCx, CPu and LH of rats treated daily for 10 days with saline or 20 mg/kg cocaine (one i.p. injection per day) and with sucrose (one administration per day) (a–c). Statistical analysis performed was one-way ANOVA followed by Newman-Keuls post hoc test. Significant differences are indicated with n = 4–5 per group. ** p < 0.01, *** p < 0.001.
Genes 12 01195 g009
Table
Table 1. Primer sequences.
Table 1. Primer sequences.
GenePrimer sequence (5′–3′)GeneBank Acc. #
Dnmt3aFP:GCTGAAGGAGAGGGAACTGA
RP:TGCCTGGAAGGTGAGTCTTG		NM_001003958
Dnmt3bFP:TGCGGTAAGAAGAACCCTGT
RP:CTGATAGCCGTCCTCATCGT		NM_001003959
Tet1FP: CTGTGGGGAATGCACCTACT
RP: TGGCTTCTTTTTGAGCACCT		XM_008774952.1
Tet2FP: AGAAGCGTAAGAAGCGCAGT
RP:TCTTTTTCATTTGACCGTCTCTTCC		XM_006224264.2
Tet3FP: TGTGTGCAAGAGGACTTTCG
RP: TACTGACGGGTGGTTTCTCC		XM_006224966
CLOCKFP: GTCATCCTTCAGTAGTCAGTCCA
RP: ACATGCCTTGTGGGATTGGT		NM_021856.2
Bmal 1FP: ACTGTCTAGGTGGAGGATTTTGG
RP: CTGGTCACCTCAAAGCGACT		NM_024362.2
Per1FP: TACCAGCCATTCCGCCTAAC
RP: CGGGGAGCTTCATAACCAGA		NM_001034125.1
Per2FP: CACCCTGAAAAGAAAGTGCGA
RP: CAACGCCAAGGAGCTCAAGT		NM_031678.1
Cry1FP: AGGACGCACAGAGTGTTGG
RP: TCCTCCCGCATGCTTTCGTATC		NM_198750.2
Cry2FP: GGGGACTACATCCGGCGATA
RP: ATGATGCACTTAGCGGCCTT		NM_133405.2
Rev-erbβFP: GGGAGGATGCATCTGGTTTG
RP: CACCTCTTTTACTGCTGGGG		NM_147210.2
NPYFP: TGGCCAGATACTACTCCGCT
RP: GCTGGATCTCTTGCCATATCTCT		NM_012614.2
DBP1FP: AAGGCAAGGAAAGTCCAGGT
RP: TGGCTGCTTCATTGTTCTTG		NM_012543.3
OrxTCCTTGGGTATTTGGACCAC
CCCAGGGAACCTTTGTAGAAG		NM_013179
36B4FP:GTGCCTCACTCCATCATCAA
RP:TCCGACTCTTCCTTTGCTTC		NM_022402
Primer sequences used for real time qPCR are indicated with gene names and GenBank/NCBI accession numbers (#). FP and RP indicate forward and reverse primers, respectively.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Saad, L.; Kalsbeek, A.; Zwiller, J.; Anglard, P. Rhythmic Regulation of DNA Methylation Factors and Core-Clock Genes in Brain Structures Activated by Cocaine or Sucrose: Potential Role of Chromatin Remodeling. Genes 2021, 12, 1195. https://doi.org/10.3390/genes12081195

AMA Style

Saad L, Kalsbeek A, Zwiller J, Anglard P. Rhythmic Regulation of DNA Methylation Factors and Core-Clock Genes in Brain Structures Activated by Cocaine or Sucrose: Potential Role of Chromatin Remodeling. Genes. 2021; 12(8):1195. https://doi.org/10.3390/genes12081195

Chicago/Turabian Style

Saad, Lamis, Andries Kalsbeek, Jean Zwiller, and Patrick Anglard. 2021. "Rhythmic Regulation of DNA Methylation Factors and Core-Clock Genes in Brain Structures Activated by Cocaine or Sucrose: Potential Role of Chromatin Remodeling" Genes 12, no. 8: 1195. https://doi.org/10.3390/genes12081195

APA Style

Saad, L., Kalsbeek, A., Zwiller, J., & Anglard, P. (2021). Rhythmic Regulation of DNA Methylation Factors and Core-Clock Genes in Brain Structures Activated by Cocaine or Sucrose: Potential Role of Chromatin Remodeling. Genes, 12(8), 1195. https://doi.org/10.3390/genes12081195

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop